Skip to main content

Liothyronine Sodium

NDC 59762-1207 · Mylan Pharmaceuticals Inc.

Generic nameliothyronine sodium

Dosage formTABLET

RouteORAL

Active ingredient(s)LIOTHYRONINE SODIUM

Strength25 ug/1

Pharmacologic classTriiodothyronine [CS], l-Triiodothyronine [EPC]

Marketing categoryNDA AUTHORIZED GENERIC

Packages

59762-1207-1 — 100 TABLET in 1 BOTTLE (59762-1207-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42794-020 — Liothyronine Sodium, 42794-131 — Liothyronine Sodium, 42794-132 — Liothyronine Sodium, 42794-133 — Liothyronine Sodium, 43063-884 — Liothyronine Sodium, 50090-3131 — Liothyronine Sodium, 50090-5586 — Liothyronine sodium, 50090-7518 — liothyronine sodium, 51407-384 — Liothyronine Sodium, 59762-1206 — liothyronine sodium, 59762-1208 — liothyronine sodium, 60793-115 — liothyronine sodium, 60793-116 — liothyronine sodium, 60793-117 — liothyronine sodium, 62756-589 — liothyronine sodium, 62756-590 — liothyronine sodium, 62756-591 — liothyronine sodium, 68071-3571 — Liothyronine Sodium, 68382-582 — Liothyronine sodium, 68382-583 — Liothyronine sodium, +30 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels